Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — Stock Valuation & Research

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

SHPH key statistics

Price$5.00
Market cap$23.82M
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
52-week range2.576-44.4
Beta1.14

Explore SHPH's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.